Deleted No
Hibernated Yes
Last Checked Dec. 12, 2021

Created

Wed Nov 10 08:00:09 +0000 2021

Likes

47

Retweets

12

Source

SocialFlow

View Raw Data

JSON Data

View on Twitter

Likely Available
Profile Image

The Economist @TheEconomist

“They’re licensing the drug very generously around the world.” @natashaloder, The Economist’s health-policy editor, explains how Merck’s molnupiravir antiviral for covid-19 is a breakthrough. Listen to “Babbage” https://t.co/ggMqIhX0S2 — PolitiTweet.org

Posted Nov. 10, 2021 Hibernated